Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

GW Pharma

This page shows the latest GW Pharma news and features for those working in and with pharma, biotech and healthcare.

Intec battered as Novartis ducks out of Accordion collaboration

Intec battered as Novartis ducks out of Accordion collaboration

Shares fell by more than 12% after the annoucement. Shares in Intec Pharma have come under pressure again, following Novartis’ decision to exit a partnership focused on its Accordion drug delivery ... Intec also has Accordion formulations of

Latest news

More from news
Approximately 7 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    A handful of legitimate companies is now pioneering these products, led by GW Pharma, the UK-headquartered firm that has been working in the area since the late 1990s. ... GW Pharma gained an historic approval for its drug Epidiolex from the FDA in June

  • Pharma deals during January 2014 Pharma deals during January 2014

    Another option, open to some European companies, is to raise cash in the US, for example, in early January GW Pharma raised $87.9m on NASDAQ. ... See a table listing all the major pharma mergers, acquisitions and collaborations agreed during January 2014.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • GW Pharmaceuticals strengthens research and development team GW Pharmaceuticals strengthens research and development team

    I look forward to contributing to GW’s drug discovery efforts and to advancing the next generation of pipeline candidates.”. ... Justin Gover, GW’s chief executive officer, said: “I am delighted to welcome Volker and Ben to GW in these important R

  • GW Pharmaceuticals promotes Adam George to MD GW Pharmaceuticals promotes Adam George to MD

    Gover said: “These important leadership appointments reflect GW’s continuing evolution into a transatlantic commercial-stage biopharmaceutical company. ... In his new role he will be tasked with ensuring GW’s UK operations achieve their strategic

  • GW Pharma appoints Julian Gangolli as North American president GW Pharma appoints Julian Gangolli as North American president

    Appointment coincides with GW Pharma’s US launch. Biopharma company GW Pharma has named Julian Gangolli as its president for North America. ... GW Pharma is also relocating its CEO, Justin Glover, to the US to support its imminent launch in the States.

  • GW hires Pfizer’s Kenneth Sommerville GW hires Pfizer’s Kenneth Sommerville

    Appointed VP clinical research at company specialising in cannabinoids. Dr Kenneth Sommerville has left his role at pharma giant Pfizer to join GW Pharma. ... This is an exciting time to be joining GW, with a number of important products currently under

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links